Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

DRUGDRUG
6 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in BRIGHT MINDS BIOSCIENCES INC

Janus Henderson Group Ltd. holds 1.3M shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), worth $93.5M as of 2026-Q1. The position was increased (+11.1% shares). DRUG represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$93.5M

Current Shares

1.3M

Total Value Change

+$75.1M

Total Shares Change

+775,548

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.3M
+11.1%
$93.5M0.0%$80.00
33
2025-Q4
Increased
1.2M
+0.9%
$90.8M0.0%$75.85
30
2025-Q3
Unchanged
1.1M
0.0%
$69.1M0.0%$57.45
0
2025-Q2
Increased
1.1M
+3.1%
$30.2M0.0%$23.27
30
2025-Q1
Increased
1.1M
+118.4%
$40.3M0.0%$36.50
47
2024-Q4
New
508,776
-
$18.4M0.0%$36.86
39

Other major holders of DRUG: BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used